113 related articles for article (PubMed ID: 16725215)
1. The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.
Blois A; Srebro B; Mandalà M; Corti A; Helle KB; Serck-Hanssen G
Regul Pept; 2006 Jul; 135(1-2):78-84. PubMed ID: 16725215
[TBL] [Abstract][Full Text] [Related]
2. Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease.
Lu L; Wang YN; Li MC; Wang HB; Pu LJ; Niu WQ; Meng H; Yang EL; Zhang RY; Zhang Q; Zhao Q; Chen QJ; De Caterina R; Shen WF
Eur Heart J; 2012 Sep; 33(18):2297-306. PubMed ID: 22645192
[TBL] [Abstract][Full Text] [Related]
3. The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration.
Belloni D; Scabini S; Foglieni C; Veschini L; Giazzon A; Colombo B; Fulgenzi A; Helle KB; Ferrero ME; Corti A; Ferrero E
FASEB J; 2007 Oct; 21(12):3052-62. PubMed ID: 17566084
[TBL] [Abstract][Full Text] [Related]
4. The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions.
Helle KB
Cardiovasc Res; 2010 Jan; 85(1):9-16. PubMed ID: 19640932
[TBL] [Abstract][Full Text] [Related]
5. CAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in endothelial cells.
Ono H; Ichiki T; Ohtsubo H; Fukuyama K; Imayama I; Iino N; Masuda S; Hashiguchi Y; Takeshita A; Sunagawa K
Hypertens Res; 2006 Jan; 29(1):39-47. PubMed ID: 16715652
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A (CGA)-derived polypeptide (CGA
Luo L; Liu S; Zhang D; Wei F; Gu N; Zeng Y; Chen X; Xu S; Liu S; Xiang T
Peptides; 2020 Sep; 131():170297. PubMed ID: 32380199
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway.
Hu C; Dandapat A; Mehta JL
Hypertension; 2007 Nov; 50(5):952-7. PubMed ID: 17893372
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of vasostatin-1 protects hypoxia/reoxygenation injuries in cardiomyocytes-endothelial cells transwell co-culture system.
Liu J; Yang D; Shi S; Lin L; Xiao M; Yuan Z; Yu M
Cell Biol Int; 2014 Jan; 38(1):26-31. PubMed ID: 23956006
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of JNK, ERK1/2, and p38 mitogen-activated protein kinases on endothelial cell tissue repair functions in response to tumor necrosis factor-α.
Kanaji N; Nelson A; Wang X; Sato T; Nakanishi M; Gunji Y; Basma H; Michalski J; Farid M; Rennard SI; Liu X
J Vasc Res; 2013; 50(2):145-56. PubMed ID: 23258237
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of vasostatin-1 protects hypoxia/reoxygenation injuries in cardiomyocytes independent of endothelial cells.
Yu M; Wang Z; Fang Y; Xiao MD; Yuan ZX; Lu CB; Lin L; Yang DC
Cardiovasc Ther; 2012 Jun; 30(3):145-51. PubMed ID: 21884005
[TBL] [Abstract][Full Text] [Related]
12. Regulatory peptides from chromogranin A and secretogranin II: putative modulators of cells and tissues involved in inflammatory conditions.
Helle KB
Regul Pept; 2010 Nov; 165(1):45-51. PubMed ID: 19800929
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibitor attenuates oxidative stress-induced endothelial cell apoptosis via p38 MAP kinase inhibition.
Yu W; Akishita M; Xi H; Nagai K; Sudoh N; Hasegawa H; Kozaki K; Toba K
Clin Chim Acta; 2006 Feb; 364(1-2):328-34. PubMed ID: 16150432
[TBL] [Abstract][Full Text] [Related]
14. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.
Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW
Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661
[TBL] [Abstract][Full Text] [Related]
15. Vasostatin-2 inhibits cell proliferation and adhesion in vascular smooth muscle cells, which are associated with the progression of atherosclerosis.
Hou J; Xue X; Li J
Biochem Biophys Res Commun; 2016 Jan; 469(4):948-53. PubMed ID: 26721428
[TBL] [Abstract][Full Text] [Related]
16. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
Viswambharan H; Ming XF; Zhu S; Hubsch A; Lerch P; Vergères G; Rusconi S; Yang Z
Circ Res; 2004 Apr; 94(7):918-25. PubMed ID: 14988229
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation.
Bai YP; Liu YH; Chen J; Song T; You Y; Tang ZY; Li YJ; Zhang GG
Biochem Biophys Res Commun; 2007 Aug; 360(1):20-6. PubMed ID: 17583675
[TBL] [Abstract][Full Text] [Related]
18. p38 Mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells.
Hashimoto S; Matsumoto K; Gon Y; Maruoka S; Takeshita I; Hayashi S; Koura T; Kujime K; Horie T
Eur Respir J; 1999 Jun; 13(6):1357-64. PubMed ID: 10445612
[TBL] [Abstract][Full Text] [Related]
19. Src kinase mediates angiotensin II-dependent increase in pulmonary endothelial nitric oxide synthase.
Li X; Lerea KM; Li J; Olson SC
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):365-72. PubMed ID: 15191917
[TBL] [Abstract][Full Text] [Related]
20. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
